These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22569585)

  • 1. Society of toxicologic pathology position paper: review series: assessment of circulating hormones in nonclinical toxicity studies: general concepts and considerations.
    Stanislaus D; Andersson H; Chapin R; Creasy D; Ferguson D; Gilbert M; Rosol TJ; Boyce RW; Wood CE
    Toxicol Pathol; 2012 Aug; 40(6):943-50. PubMed ID: 22569585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Society of Toxicologic Pathology position paper on best practices on recovery studies: the role of the anatomic pathologist.
    Perry R; Farris G; Bienvenu JG; Dean C; Foley G; Mahrt C; Short B;
    Toxicol Pathol; 2013; 41(8):1159-69. PubMed ID: 23531793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response letter from Clinical Pathology Interest Group of the Society of Toxicologic Pathology (STP) for manuscript entitled International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies by Bolon et al.
    Tripathi NK; Schultze AE; Pearson RC; Everds NE; Elliott GS; Ramaiah L; Wells MY; Latimer KS; Walter GL; Katavolos P; Collins ND; Tarrant J; Walker DB; Topper MJ; Jordan HL; O'Rourke LG; Guilpin VB; Brockus CW; Wilcox AL; Clemo FA; Smith GS; Reagan WJ; McCartney JE
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):39. PubMed ID: 21676604
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations for the evaluation of pathology data in nonclinical safety biomarker qualification studies.
    Burkhardt JE; Pandher K; Solter PF; Troth SP; Boyce RW; Zabka TS; Ennulat D
    Toxicol Pathol; 2011 Dec; 39(7):1129-37. PubMed ID: 22116771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STP position paper: interpreting the significance of increased alveolar macrophages in rodents following inhalation of pharmaceutical materials.
    Nikula KJ; McCartney JE; McGovern T; Miller GK; Odin M; Pino MV; Reed MD
    Toxicol Pathol; 2014; 42(3):472-86. PubMed ID: 24178583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STP position paper: Recommended practices for sampling and processing the nervous system (brain, spinal cord, nerve, and eye) during nonclinical general toxicity studies.
    Bolon B; Garman RH; Pardo ID; Jensen K; Sills RC; Roulois A; Radovsky A; Bradley A; Andrews-Jones L; Butt M; Gumprecht L
    Toxicol Pathol; 2013; 41(7):1028-48. PubMed ID: 23475559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies.
    Bolon B; Barale-Thomas E; Bradley A; Ettlin RA; Franchi CA; George C; Giusti AM; Hall R; Jacobsen M; Konishi Y; Ledieu D; Morton D; Park JH; Scudamore CL; Tsuda H; Vijayasarathi SK; Wijnands MV
    Exp Toxicol Pathol; 2011 Jan; 63(1-2):187-95. PubMed ID: 20724123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory Forum opinion piece: image analysis-based cell proliferation studies using electronic images: the CEPA industry working group's proposal.
    Dölemeyer A; Mudry MC; Kohler M; Schorsch F
    Toxicol Pathol; 2013; 41(8):1170-3. PubMed ID: 23827979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scientific and Regulatory Policy Committee Points to Consider*: Review of Scientific and Regulatory Policy Committee Points to Consider: Review of Current Practices for Ultrastructural Pathology Evaluations in Support of Nonclinical Toxicology Studies.
    Keirstead ND; Janovitz EB; Meehan JT; LeRoy BE; Megill JR; Peterson RA; Masson RG; Marxfeld HA
    Toxicol Pathol; 2019 Jun; 47(4):461-468. PubMed ID: 31018785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STP Best Practices for Evaluating Clinical Pathology in Pharmaceutical Recovery Studies.
    Tomlinson L; Ramaiah L; Tripathi NK; Barlow VG; Vitsky A; Poitout-Belissent FM; Bounous DI; Ennulat D
    Toxicol Pathol; 2016 Feb; 44(2):163-72. PubMed ID: 26879687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of circulating hormones in regulatory toxicity studies II. Male reproductive hormones.
    Chapin RE; Creasy DM
    Toxicol Pathol; 2012 Oct; 40(7):1063-78. PubMed ID: 22552397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicologic Pathology Forum*: Opinion on Sexual Maturity and Fertility Assessment in Long-tailed Macaques ( Macaca fascicularis) in Nonclinical Safety Studies.
    Mecklenburg L; Luetjens CM; Weinbauer GF
    Toxicol Pathol; 2019 Jun; 47(4):444-460. PubMed ID: 30898082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicologic Pathology Forum: Current Status on the Use of Animal Models of Human Disease in the Pharmaceutical Industry in Japan in Nonclinical Safety Assessment-Opinion Paper.
    Tomohiro M; Okabe T; Kimura Y; Kinoshita K; Maeda M; Mitobe Y; Motoyama K; Yonezawa R; Sasaki S; Fujiwara M; Watanabe K
    Toxicol Pathol; 2019 Feb; 47(2):108-120. PubMed ID: 30636562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subsite awareness in neuropathology evaluation of National Toxicology Program (NTP) studies: a review of select neuroanatomical structures with their functional significance in rodents.
    Rao DB; Little PB; Sills RC
    Toxicol Pathol; 2014; 42(3):487-509. PubMed ID: 24135464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct dosing of preweaning rodents in toxicity testing and research: deliberations of an ILSI RSI Expert Working Group.
    Moser VC; Walls I; Zoetis T
    Int J Toxicol; 2005; 24(2):87-94. PubMed ID: 16036767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Society of Toxicologic Pathology position paper: organ weight recommendations for toxicology studies.
    Sellers RS; Morton D; Michael B; Roome N; Johnson JK; Yano BL; Perry R; Schafer K
    Toxicol Pathol; 2007 Aug; 35(5):751-5. PubMed ID: 17849358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal Organ Development as a Complicating Factor in Juvenile Toxicity Studies in Rats.
    Picut CA; Parker GA
    Toxicol Pathol; 2017 Jan; 45(1):248-252. PubMed ID: 27753635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compilation of international regulatory guidance documents for neuropathology assessment during nonclinical general toxicity and specialized neurotoxicity studies.
    Bolon B; Bradley A; Butt M; Jensen K; Krinke G; Mellon RD
    Toxicol Pathol; 2011 Jan; 39(1):92-6. PubMed ID: 21119055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Study Design Variables on Clinical Pathology Data.
    Aulbach A; Provencher A; Tripathi N
    Toxicol Pathol; 2017 Feb; 45(2):288-295. PubMed ID: 28178900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity assessment strategies, data requirements, and risk assessment approaches to derive health based guidance values for non-relevant metabolites of plant protection products.
    Dekant W; Melching-Kollmuss S; Kalberlah F
    Regul Toxicol Pharmacol; 2010 Mar; 56(2):135-42. PubMed ID: 19883711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.